Steven J Clapcote (Steve Clapcote)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 10

Top Topics

Spectrum Disorder

Endoplasmic Reticulum

Mild Cognitive Impairment

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Disease models & mechanisms

Psychological medicine

Behavioral neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Armstrong, Hüseyin Güngör, Pariya Anongjanya, Clare Tweedy, Edward Parkin, Jamie Johnston, Ian M Carr, Neil Dawson, Steven J Clapcote
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (10) (2024)
Paul Armstrong, Hüseyin Güngör, Pariya Anongjanya, Clare Tweedy, Edward Parkin, Jamie Johnston, Ian M Carr, Neil Dawson, Steven J Clapcote
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (10) (2024)
Paul Armstrong, Hüseyin Güngör, Pariya Anongjanya, Clare Tweedy, Edward Parkin, Jamie Johnston, Ian M Carr, Neil Dawson, Steven J Clapcote
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (10) (2024)
Paul Armstrong, Hüseyin Güngör, Pariya Anongjanya, Clare Tweedy, Edward Parkin, Jamie Johnston, Ian M Carr, Neil Dawson, Steven J Clapcote
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Paul Armstrong, Hüseyin Güngör, Pariya Anongjanya, Clare Tweedy, Edward Parkin, Jamie Johnston, Ian M Carr, Neil Dawson, Steven J Clapcote
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (10) (2024)
Iain D Wilkinson, Tariq Mahmood, Sophia Faye Yasmin, Anneka Tomlinson, Jamshid Nazari, Hamid Alhaj, Soumaya Nasser El Din, Joanna Neill, Chhaya Pandit, Shahzad Ashraf, Alastair G Cardno, Steven J Clapcote, Chris F Inglehearn, Peter W Woodruff
In memory of Professor Iain Wilkinson: cognitive and neuroimaging endophenotypes in a consanguineous schizophrenia multiplex family. Psychological medicine (2022)
Steven J Clapcote
How can we obtain truly translational mouse models to improve clinical outcomes in schizophrenia? Disease models & mechanisms 15 (11) (2022)
Hannah W Y Ng, Jennifer A Ogbeta, Steven J Clapcote
Genetically altered animal models for ATP1A3-related disorders. Disease models & mechanisms 14 (10) (2021)
Min Liu, Marie Fitzgibbon, Yanqin Wang, Jamie Reilly, Xiaohong Qian, Timothy O'Brien, Steven J Clapcote, Sanbing Shen, Michelle Roche
Ulk4 regulates GABAergic signaling and anxiety-related behavior. Translational psychiatry 8 (1) (2018)
Greer S Kirshenbaum, James Dachtler, John C Roder, Steven J Clapcote
Characterization of cognitive deficits in mice with an alternating hemiplegia-linked mutation. Behavioral neuroscience 129 (6) (2015)